Expression of HLA-E was generally low, but significantly increased on CD4+ cells from primary progressive MS patients when compared with healthy controls (p<0.005) and relapsing remitting MS patients (p<0.031). This evidence concerns the gene HLA-E and primary progressive multiple sclerosis.